CERo Therapeutics Holdings - Warrants (13/02/2029) Common Stock

The latest common stock for CEROW is $92K as of June 2026. That compares with $120 in the prior-year period — up 77110.9% year over year. Investors often review this figure alongside CERo Therapeutics Holdings - Warrants (13/02/2029)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, CEROW's common stock moved from $120 to $92K — a 77110.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in CERo Therapeutics Holdings - Warrants (13/02/2029)'s operating scale or balance-sheet position.

A common stock figure of $92K for CEROW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting CEROW's common stock ($92K), review year-over-year change from $120, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.